Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
about
Immune-escape mutations and stop-codons in HBsAg develop in a large proportion of patients with chronic HBV infection exposed to anti-HBV drugs in Europe.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@en
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@nl
type
label
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@en
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@nl
prefLabel
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@en
Immune-escape mutations and st ...... d to anti-HBV drugs in Europe.
@nl
P2093
P2860
P50
P1476
Immune-escape mutations and st ...... ed to anti-HBV drugs in Europe
@en
P2093
Adriana Vince
Annemarie M J Wensing
Bianca Bruzzone
Charles A B Boucher
Dimitros Paraskevis
Domenico Di Carlo
Elisabeth Puchhammer-Stöckl
Federico Garcia
François Simon
Greet Boland
P2860
P2888
P356
10.1186/S12879-018-3161-2
P577
2018-06-01T00:00:00Z
P6179
1104354032